Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/11531
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: C2-ceramide primes specifically for superoxide anion production induced by N-formyl-methionyl-leucine-phenylalanine (fMLP) in human neutrophils
Author: Richard, A.
Bourgoin, S.
Naccache, P.
L'Heureux, G.
Krump, E.
McColl, S.
Pelletier, G.
Citation: BBA: General Subjects, 1996; 1299(2):259-266
Publisher: Elsevier BV
Issue Date: 1996
ISSN: 0304-4165
1878-2434
Statement of
Responsibility: 
Richard, Alain; Bourgoin, Sylvain; Naccache, Paul H.; L'Heureux, Gaétan P.; Krump, Eric; McColl, Shaun R.; Pelletier, Guy
Abstract: Activated sphingomyelinases release ceramide molecules believed to be involved in intracellular signalling. The present study investigated whether soluble C2-ceramide modulates some of the effects of N-formylmethionylleucyl phenylalanine (fMLP) and other agonists on human neutrophils (or polymorphonuclear leukocytes-PMN); principally superoxide anion (O2-) production. The preincubation of PMN for 15 min with C2-ceramide increased by up to almost 3-fold the amounts of O2- generated in response to 0.1 and 1 microM fMLP. Priming was detected at C2-ceramide concentrations of 2 microM to 4 microM per million PMN. Though less potent than C2-ceramide, C6-ceramide (N-hexanoylsphingosine) could prime for O2- generated in response to 0.1 microM fMLP, with maximal effects obtained at 10-20 microM. In contrast, micromolar concentrations of sphingosine, dihydroceramide, and ceramide-phosphate, failed to exert any potentiating effect on fMLP-induced O2- generation. As expected, TNF-alpha (1000 U/ml), also primed for fMLP-induced O2- production; however, the combination of TNF-alpha and C2-ceramide showed no additive effect. Moreover, S. aureus sphingomyelinase (0.1 U/ml), was unable to reproduce the priming effects of C2-ceramide and TNF-alpha. C2-ceramide at 2 microM did not enhance the production of O2- induced by 100 nM recombinant human interleukin-8 (IL-8), leukotriene B4 (LTB4), platelet-activating factor (PAF) or 20 mM sodium fluoride (NaF). Furthermore, C2-ceramide (2 microM) did not enhance the mobilization of calcium, the release of arachidonic acid or the accumulation of phosphatidylethanol, induced by 100 nM fMLP. This suggests that probably neither phospholipases C, A2 or D (PLC, PLA2, PLD) were involved in the priming effect by C2-ceramide. However, C2-ceramide inhibited in a dose-related manner the production of O2- induced by phorbol 12-myristate 13-acetate (PMA) and mezerein. Furthermore, PMA-stimulated PLD activity was also significantly reduced by a preincubation of PMN with C2-ceramide. The priming of O2- production by C2-ceramide could involve yet unidentified mechanisms specific for fMLP, or it might imply that cytokines such as TNF-alpha have different mechanisms than C2-ceramide.
Keywords: Neutrophils
Humans
Superoxides
Calcium
Sphingomyelin Phosphodiesterase
Ceramides
Arachidonic Acid
N-Formylmethionine Leucyl-Phenylalanine
Signal Transduction
Drug Interactions
DOI: 10.1016/0005-2760(95)00215-4
Published version: http://dx.doi.org/10.1016/0005-2760(95)00215-4
Appears in Collections:Aurora harvest 7
Microbiology and Immunology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.